Hypothesis

Reelin signaling in layer II stellate cells of the entorhinal cortex (EC) regulates the excitability of grid cells and thereby controls the activity‑dependent release of tau protein. Loss of reelin leads to hippocampal‑independent hyperactivity of grid cells, increased calcium influx through NMDA receptors, calbindin depletion, and preferential secretion of truncated, aggregation‑prone tau species that act as prion‑like seeds. This mechanism explains why posterior‑lateral EC subfields (ELc, ECL, lateral EC) show the earliest tau burden and why grid‑cell dysfunction precedes measurable hippocampal tau accumulation.

Mechanistic Rationale

• Reelin‑dependent NMDA modulation: Reelin binds ApoER2 and VLDLR receptors, enhancing NMDA receptor currents via Src family kinase Fyn. In reelin‑deficient stellate cells, NMDA signaling becomes dysregulated, causing prolonged calcium entry that overwhelms calbindin buffering capacity (calcium buffer loss).
• Activity‑tau coupling: Elevated intracellular calcium promotes calcium‑dependent proteases (calpains) that truncate tau at Asp421, generating the PHF‑core fragment that seeds aggregation (PHF‑core tau as prion‑like seeds). Truncated tau is preferentially released via activity‑dependent exocytosis from synaptic vesicles.
• Grid‑cell specificity: Grid cells fire in rhythmic theta‑band bursts during spatial navigation. Their high firing rates make them especially vulnerable to calcium overload when reelin signaling is compromised, linking spatial navigation deficits directly to tau seeding (NFTs in EC impair path integration).
• Regional vulnerability: Posterior‑lateral EC subfields express the highest density of reelin‑positive stellate cells and exhibit the strongest baseline grid‑cell firing (posterior‑lateral subfields as earliest tau accumulation sites). Consequently, they experience the earliest calcium‑driven tau truncation and seeding.

Testable Predictions

1. In vivo rescue: Conditional overexpression of reelin in EC layer II stellate cells of APP/PS1;tau mice will reduce extracellular PHF‑core tau levels in the EC (measured by tau‑ELISA of interstitial fluid) and delay the appearance of tau PET signal in hippocampal CA1 by ≥30 % compared with littermate controls.
2. Electrophysiological signature: Mice with EC‑specific reelin knockout will show increased grid‑cell burst frequency and prolonged post‑burst calcium transients (detected via GCaMP imaging) that correlate with elevated secreted tau measured in hippocampal slices.
3. Pharmacological block: Acute NMDA receptor antagonism (e.g., low‑dose memantine) administered to reelin‑deficient mice will normalize calcium influx, decrease calpain‑mediated tau truncation, and attenuate tau spread to the hippocampus without affecting amyloid‑β load.
4. Human biomarker correlation: In preclinical AD subjects, lower CSF reelin levels will predict higher EC‑specific tau‑PET signal and worse performance on virtual navigation tasks, independent of amyloid‑β burden.

Falsifiability

If reelin overexpression fails to reduce extracellular tau or slow hippocampal tau accumulation, or if NMDA blockade does not rescue calcium dynamics and tau secretion in reelin‑deficient EC stellate cells, the hypothesis would be falsified. Likewise, discovering that grid‑cell activity changes occur only after hippocampal tau accumulation would undermine the proposed directionality.

Experimental Approach (brief)

• Use Cre‑driver lines (Cux2‑CreERT2) to manipulate reelin expression specifically in EC layer II.
• Combine in vivo two‑photon calcium imaging of grid cells with microdialysis for tau species.
• Apply tau‑seeding assays (biosensor cells) to interstitial fluid collected from EC and hippocampus.
• Correlate findings with behavioral assays of path integration (virtual radial maze) and tau‑PET imaging in transgenic mice and, where possible, in human cohorts using existing ADNI/HABS datasets (epidemic spreading models recapitulate tau patterns).

By linking reelin signaling, grid‑cell excitability, and calcium‑driven tau truncation, this hypothesis offers a mechanistic bridge between the observed selective vulnerability of EC stellate cells and the prion‑like spread of tau that drives early cognitive decline in Alzheimer’s disease.